We are live on ! Find out more
TRIB

Trinity Biotech
TRIB

37 hedge funds and large institutions have $37.3M invested in Trinity Biotech in 2019 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more capital invested

Capital invested by funds: $30.2M → $37.3M (+$7.05M)

0% less ownership

Funds ownership: 0.09% → 0.09% (-0%)

9% less repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 11

8% less funds holding

Funds holding: 40 → 37 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.8%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
–
Increased
10
Reduced
11
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HAIM
Hunter Associates Investment Management
Pennsylvania
+$289K
2
Russell Investments Group
Russell Investments Group
United Kingdom
+$286K
3
FM
Fondren Management
Texas
+$84.1K
4
SCM
Stonehill Capital Management
New York
+$50.3K
5
Renaissance Technologies
Renaissance Technologies
New York
+$49.9K

Top Sellers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$489K
2
Boston Partners
Boston Partners
Massachusetts
-$257K
3
BlackRock
BlackRock
New York
-$141K
4
ARM
Adirondack Research & Management
New York
-$45.8K
5
TA
Teton Advisors
New York
-$29.7K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Stonehill Capital Management
New York
$4.72M +$50.3K +122 +1%
PIM
2
Paradice Investment Management
Colorado
$4.51M – – –
Janus Henderson Group
3
Janus Henderson Group
United Kingdom
$3.45M -$489K -1,187 -13%
HAIM
4
Hunter Associates Investment Management
Pennsylvania
$3.07M +$289K +700 +11%
FWSM
5
First Wilshire Securities Management
California
$2.8M -$23.5K -57 -0.9%
2L
6
22NW LP
Washington
$2.72M – – –
Russell Investments Group
7
Russell Investments Group
United Kingdom
$2.69M +$286K +694 +12%
HA
8
Heartland Advisors
Wisconsin
$2.52M – – –
LAM
9
Lapides Asset Management
Connecticut
$1.87M +$37.9K +92 +2%
Renaissance Technologies
10
Renaissance Technologies
New York
$1.75M +$49.9K +121 +3%
ARM
11
Adirondack Research & Management
New York
$1.57M -$45.8K -111 -3%
Morgan Stanley
12
Morgan Stanley
New York
$1.33M +$825 +2 +0.1%
Boston Partners
13
Boston Partners
Massachusetts
$1.29M -$257K -623 -17%
FM
14
Fondren Management
Texas
$1.05M +$84.1K +204 +9%
Millennium Management
15
Millennium Management
New York
$441K -$3.3K -8 -0.8%
TA
16
Teton Advisors
New York
$371K -$29.7K -72 -8%
State Street
17
State Street
Massachusetts
$335K – – –
WPC
18
White Pine Capital
Minnesota
$230K +$4.12K +10 +2%
Deutsche Bank
19
Deutsche Bank
Germany
$118K -$12.4K -30 -10%
Two Sigma Advisers
20
Two Sigma Advisers
New York
$94K -$3.3K -8 -4%
California Public Employees Retirement System
21
California Public Employees Retirement System
California
$80K – – –
RC
22
RBF Capital
California
$43K – – –
Geode Capital Management
23
Geode Capital Management
Massachusetts
$39K – – –
TRCT
24
Tower Research Capital (TRC)
New York
$39K +$5.77K +14 +18%
Verition Fund Management
25
Verition Fund Management
Connecticut
$34K – – –
1
2

TRIB Hedge Fund Activity: Q1 2019 in Review

37 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Trinity Biotech (TRIB) for Q1 2019, worth a combined $37.3M — up 23% from $30.2M a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of TRIB and 0 opened new positions — a net loss of 2 holders — while 11 trimmed existing stakes and 10 added.

The largest buyer was Hunter Associates Investment Management, adding an estimated $289K. The largest seller was Janus Henderson Group, cutting an estimated $489K.

  • 37 institutional investors held Trinity Biotech (TRIB) as of Q1 2019, down from 40 in Q4 2018.
  • Funds reported $37.3M of Trinity Biotech stock for Q1 2019, up 23% quarter-over-quarter.
  • 0 funds opened new Trinity Biotech positions in Q1 2019 and 2 closed out, a net change of -2 holders.
  • The largest Trinity Biotech buyer in Q1 2019 was Hunter Associates Investment Management, an estimated $289K added.
  • The largest Trinity Biotech seller in Q1 2019 was Janus Henderson Group, an estimated $489K sold.

Based on aggregated 13F filings for Q1 2019.